Studi Penggunaan Sefalosporin Generasi Ketiga pada Pasien Pneumonia di Instalasi Rawat Inap Rumah Sakit Umum Haji Surabaya

Natania Imanuella Worotikan, Didik Hasmono, Elisabeth Kasih, Dewi Ramdani

Abstract


Pneumonia is an acute lung tissue infection caused by inflammation of the lung parenchyma and the presence of exudate compaction in lung tissue. Based on epidemiology, pneumonia can be differentiated into communityacquired pneumonia and health care-associated pneumonia. The HCAP category divided pneumonia into hospital acquired pneumonia and ventilator-associated pneumonia. This study aims to analyze the pattern of third generation cephalosporin use in pneumonia patients based on drug route of administration, dosage, frequency, interval and duration of drug usage, and laboratory data. This study was conducted retrospectively with time limited sampling method during the period of August 1, 2016 - August 31, 2017. The study was conducted in 31 patients with diagnosis of pneumonia undergoing hospitalization and received third generation cephalosporin antibiotic therapy at inpatient installation of RSU Haji Surabaya which traced through Medical Record. All samples were recorded on the data collection sheet, and then the data was recapitulated and analyzed. Based on the observation result, it was found that ceftriaxone with frequency and dose 2x1 g (iv) used as much as 41% (11 people), the combination between ceftriaxone 2x1 g (iv) with levofloxacin 1x1 g (iv) used as much as 22% (4 people). The longest use of third generation cephalosporin antibiotics was ceftriaxone (4-6 days) as much as 35%
(12 people).

Save to Mendeley


Full Text:

PDF

References


Baharirama Made., dan Artini I.G.A. 2017. Pola Pemberian Antibiotika Untuk Pasien Community Acquired Pneumonia di Instalasi Rawat Inap RSUD Buleleng Tahun 2013, E-Jurnal Medika: Bali. https://ojs.unud.ac.id/ index.php/ eum/article/view/29107/18070.

Bradley, J.S., 2011. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Month of Age: Clinical Practice Guideline by the Pediatric Infectious Diseases Society of America. IDSA Guideline: Pediatric Community Pneumonia Guideline.

Chambers, H.F. 2007,Beta-Lactam Antibiotic & Other Inhibitor of Cell Wall Synthesis, in Katzung, B. G. Basic and Clinical Pharmacology, Ed. 10th, Ed, McGraw-Hill, New York.

Cunha, B.A. and Burke, M.D.2013,Community Acquired Pneumonia. [diperbaharui 13 Januari 2014; Diakses 30 September 2017]. Dari http://emedicine.medscape.com /article/234240-overview#a1.

Dahlan, Zul, 2014. Buku Ajar Ilmu Penyakit Dalam Jilid II. Edisi 6, Jakarta: Balai Penerbit FKUI, hal 1608-1624.

Depkes RI [Departemen Kesehatan Republik Indonesia], 2013, Riset Kesehatan Dasar 2013, Kesehatan, B. P. dan P., ed., Kementrian Kesehatan Republik Indonesia, Jakarta.

Depkes RI [Departemen Kesehatan Republik Indonesia].

Peraturan Menteri Kesehatan Republik Indonesia Nomor 2406/MENKES/PER/XII/2011 tentang Pedoman Umum Penggunaan Antibiotika. Jakarta: Departemen Kesehatan RI.

Farida Y., Trisna, A.O, Nur D., 2017, Study of Antibiotic Use on Pneumonia Patient in Surakarta Referral Hospital, Journal of Pharmaceutical Science and Clinical Research, 2: 44-52.

Gilbert, G.L.,2015,Knowing When to Stop Antibiotic Therapy. Marie Bashir Institute for Infectious Diseases and Biosecurity. Med J Aust 2015,202: 121-122.

Goodman and Gilman., 2012. Dasar Farmakologi Terapi, Editor Joel G., Hardman, L.E., Limbird, Konsultan Editor Alfred Goodman Gilman, Alih bahasa Tim Ahli Bahasa Sekolah Farmasi ITB, Edisi 10. Penerbit EGC,Jakarta.

Gunawan, S.G., et al. 2013. Farmakologi dan Terapi (edisi 5, hal. 585-591 ; 666- 669). Jakarta : Departemen Farmakologi dan Terapeutik Fakultas Kedokteran Universitas Indonesia.

Hartati S,. 2012. Analisis Faktor Risiko Yang Berhubungan dengan Kejadian Pneumonia pada Anak Balita Di RSUD Pasar Rebo Jakarta. Skripsi. Jakarta: Universitas Indonesia.

High, K., 2015. Evaluation of Infection in the Older Adult. Diakses dari http://www.uptodate.com/contens/evaluation-of-ifection-in -the-older-adult pada tanggal 25 Februari 2018.

Hussain, F., Arayne, M.S., and Sultana, 2006, Interactions between sparfloxacin and antacids dissolution and adsorption studies. N. Pak. J.Pharm. Sci, 19: (1), 16-21.

Juwita, D.A, Arifi, H.dan Yuliati, N. 2017. Kajian Deskriptif Retrospektif Regimen Dosis Antibiotik Pasien Pneumonia Anak di RSUP. Dr. M. Damil Padang. Jurnal Sains Farmasi & Klinis, 3(2):128-133.

Kaparang, P.C., Heedy, T.dan Paulina V.Y.Y., 2014, Evaluasi Kerasioanal Antibiotika Pada Pengobatan Pneumonia Anak Di Instalasi Rawat Inap RSUP Prof. Dr. R. D. Kondou Monado Periode Januari Desember 2013, Jurnal IlmiahFarmasiPharmacon,3(3):247-253.

Kaysin, A. and Viera, A. 2016, Community-Acquired Pneumonia in Adults: Diagnosis and Management, American Family Physician, 94(9):698-706.

Misnadiarly, 2008, Penyakit Infeksi Saluran Napas Pneumonia pada Balita, Orang Dewasa, Usia Lanjut, Pustaka Obor Populer, Jakarta.

Perhimpunan Dokter Paru Indonesia. 2014, Pneumonia Komuniti: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Edisi II. Jakarta: Balai Penerbit FK UI.

Risnawati, D.2015,Gambaran Hasil foto Toraks Pada Pasien Baru di Bagian/SMF Radiologi FK UNSRAT BLU RSUP Prof.Dr. R.D Kandou Manado Periode Juni-Oktober 2014. Jurnal E-Clinic, 3(1):48-53.

Rizqi, M.H. dan Helmia, H., 2014, Tinjauan Imunologi Pneumonia pada Pasien Geriatri, CDK-21241(1): 14-18.

Sandora, T.J., and Sectish,T.C. Community-Acquired Pneumonia in:Kliegman,R.M., Stanton,B.F.,Geme,J.W., Schor,N.F.,and Behrman,R.E. 2011, Nelson Textbook of Pediatrics. 19th Ed,AnImprint of Elsevier Inc, Philadelphia.

Triono, A.A dan Purwoko, A.E, 2012, Efektifitas Antibiotik Golongan Sefalosporin dan Kuinolon terhadap Infeksi Saluran Kemih, Mutiara Medika, 12(1): 6 -11.




DOI: https://doi.org/10.33508/jfst.v6i2.2233